Skip to content

Deferred Tax Assets at other companies

Omnicell logo
OmnicellOMCL
$54.06M-11.9%
Cencora logo
CencoraCOR
$192.83M-17.5%
GHC
Graham HoldingsGHC
$9.91M+10.5%

Other financials

Income statement

See full
Revenue$336.6M+2.2%
Gross profit$76.3M+18.6%
Operating income$17.7M+35.9%
Net income$13.3M+40.7%
EPS (diluted)$0.21+40.0%

Balance sheet

See full
Cash & equivalents$64.9M+364%
Total debt$36.9M+29.6%
Total equity$232.4M+42.4%
Total assets$426.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M-65.5%
CapEx$495.0K-78.0%
Free cash flow$34.1M+69.8%

Valuation

See full
Market cap$2.48B+80.1%
Enterprise value$2.45B+76.1%
P/E46.8×
P/S1.7×+0.6×

Profitability

See full
Gross margin20.9%+1.1pp
Operating margin5.3%
Net margin3.6%+2.1pp

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.2×0.0×
Current ratio1.5×+0.3×

Where this comes from

Reported directly by Guardian Pharmacy Services in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxAssetsNet.

The official record: Guardian Pharmacy Services’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardian Pharmacy Services's deferred tax assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Guardian Pharmacy Services's deferred tax assets?
Guardian Pharmacy Services (GRDN) reported deferred tax assets of $2.2M in Q1 2026.
How has Guardian Pharmacy Services's deferred tax assets changed year-over-year?
Guardian Pharmacy Services's deferred tax assets decreased by 58.3% year-over-year, from $5.27M to $2.2M.
What does deferred tax assets mean?
Represents future tax benefits arising from temporary differences between the book value of assets/liabilities and their tax basis, or from carry-forward tax losses. These assets are realized when the firm generates sufficient taxable income to offset these differences. It serves as an indicator of future tax savings potential.